-
Durvalumab with olaparib and paclitaxel for high-risk HER2-negative stage II/III breast cancer: Results from the adaptively randomized I-SPY2 trial. Cancer Cell. 2021 Jul 12; 39(7):989-998.e5.
Pusztai L, Yau C, Wolf DM, Han HS, Du L, Wallace AM, String-Reasor E, Boughey JC, Chien AJ, Elias AD, Beckwith H, Nanda R, Albain KS, Clark AS, Kemmer K, Kalinsky K, Isaacs C, Thomas A, Shatsky R, Helsten TL, Forero-Torres A, Liu MC, Brown-Swigart L, Petricoin EF, Wulfkuhle JD, Asare SM, Wilson A, Singhrao R, Sit L, Hirst GL, Berry S, Sanil A, Asare AL, Matthews JB, Perlmutter J, Melisko M, Rugo HS, Schwab RB, Symmans WF, Yee D, Van't Veer LJ, Hylton NM, DeMichele AM, Berry DA, Esserman LJ. PMID: 34143979.
View in:
PubMed Mentions: Fields:
-
Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2021 01 06; 19(1):77-102.
Daly MB, Pal T, Berry MP, Buys SS, Dickson P, Domchek SM, Elkhanany A, Friedman S, Goggins M, Hutton ML, CGC , Karlan BY, Khan S, Klein C, Kohlmann W, CGC , Kurian AW, Laronga C, Litton JK, Mak JS, LCGC , Menendez CS, Merajver SD, Norquist BS, Offit K, Pederson HJ, Reiser G, CGC , Senter-Jamieson L, CGC , Shannon KM, Shatsky R, Visvanathan K, Weitzel JN, Wick MJ, Wisinski KB, Yurgelun MB, Darlow SD, Dwyer MA. PMID: 33406487.
View in:
PubMed Mentions:
7 Fields:
-
Real-world data from a molecular tumor board demonstrates improved outcomes with a precision N-of-One strategy. Nat Commun. 2020 10 02; 11(1):4965.
Kato S, Kim KH, Lim HJ, Boichard A, Nikanjam M, Weihe E, Kuo DJ, Eskander RN, Goodman A, Galanina N, Fanta PT, Schwab RB, Shatsky R, Plaxe SC, Sharabi A, Stites E, Adashek JJ, Okamura R, Lee S, Lippman SM, Sicklick JK, Kurzrock R. PMID: 33009371.
View in:
PubMed Mentions:
8 Fields:
Translation:
Humans
-
Management of Chimeric Antigen Receptor (CAR) T-Cell Toxicities: A Review and Guideline for Emergency Providers. J Emerg Med. 2020 Jul; 59(1):61-74.
Gupta R, Roach C, Hryniewicki AT, Vilke GM, Shatsky RA, Coyne CJ. PMID: 32473867.
View in:
PubMed Mentions:
1 Fields:
Translation:
HumansCells
-
Effect of Pembrolizumab Plus Neoadjuvant Chemotherapy on Pathologic Complete Response in Women With Early-Stage Breast Cancer: An Analysis of the Ongoing Phase 2 Adaptively Randomized I-SPY2 Trial. JAMA Oncol. 2020 05 01; 6(5):676-684.
Nanda R, Liu MC, Yau C, Shatsky R, Pusztai L, Wallace A, Chien AJ, Forero-Torres A, Ellis E, Han H, Clark A, Albain K, Boughey JC, Jaskowiak NT, Elias A, Isaacs C, Kemmer K, Helsten T, Majure M, Stringer-Reasor E, Parker C, Lee MC, Haddad T, Cohen RN, Asare S, Wilson A, Hirst GL, Singhrao R, Steeg K, Asare A, Matthews JB, Berry S, Sanil A, Schwab R, Symmans WF, van 't Veer L, Yee D, DeMichele A, Hylton NM, Melisko M, Perlmutter J, Rugo HS, Berry DA, Esserman LJ. PMID: 32053137.
View in:
PubMed Mentions:
52 Fields:
Translation:
HumansCTClinical Trials
-
Adult Cancer Pain, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2019 08 01; 17(8):977-1007.
Swarm RA, Paice JA, Anghelescu DL, Are M, Bruce JY, Buga S, Chwistek M, Cleeland C, Craig D, Gafford E, Greenlee H, Hansen E, Kamal AH, Kamdar MM, LeGrand S, Mackey S, McDowell MR, Moryl N, Nabell LM, Nesbit S, BCPS , O'Connor N, Rabow MW, Rickerson E, Shatsky R, Sindt J, Urba SG, Youngwerth JM, Hammond LJ, Gurski LA. PMID: 31390582.
View in:
PubMed Mentions:
21 Fields:
Translation:
Humans
-
Next-Generation Sequencing of Tissue and Circulating Tumor DNA: The UC San Diego Moores Center for Personalized Cancer Therapy Experience with Breast Malignancies. . 2019 05; 18(5):1001-1011.
Shatsky R, Parker BA, Bui NQ, Helsten T, Schwab RB, Boles SG, Kurzrock R. PMID: 30926636.
View in:
PubMed Mentions:
-
Management of Immune Checkpoint Inhibitor Toxicities: A Review and Clinical Guideline for Emergency Physicians. J Emerg Med. 2018 10; 55(4):489-502.
Hryniewicki AT, Wang C, Shatsky RA, Coyne CJ. PMID: 30120013.
View in:
PubMed Mentions:
15 Fields:
Translation:
Humans
-
Application of the MASCC and CISNE Risk-Stratification Scores to Identify Low-Risk Febrile Neutropenic Patients in the Emergency Department. Ann Emerg Med. 2017 Jun; 69(6):755-764.
Coyne CJ, Le V, Brennan JJ, Castillo EM, Shatsky RA, Ferran K, Brodine S, Vilke GM. PMID: 28041827.
View in:
PubMed Mentions:
10 Fields:
Translation:
Humans
-
Afatinib in the treatment of breast cancer. Expert Opin Investig Drugs. 2014 Jul; 23(7):1039-47.
Hurvitz SA, Shatsky R, Harbeck N. PMID: 24870559.
View in:
PubMed Mentions:
10 Fields:
Translation:
Humans
-
Noninfectious pneumonitis with the use of mTOR inhibitors in breast cancer. Cancer Treat Rev. 2014 Mar; 40(2):320-6.
Peddi PF, Shatsky RA, Hurvitz SA. PMID: 24011786.
View in:
PubMed Mentions:
7 Fields:
Translation:
HumansCells
-
Multiplex PCR-ligation detection reaction assay for simultaneous detection of drug resistance and toxin genes from Staphylococcus aureus, Enterococcus faecalis, and Enterococcus faecium. J Clin Microbiol. 2010 Jan; 48(1):277-80.
Granger K, Rundell MS, Pingle MR, Shatsky R, Larone DH, Golightly LM, Barany F, Spitzer ED. PMID: 19864481.
View in:
PubMed Mentions:
3 Fields:
Translation:
HumansCells
-
Multiplexed identification of blood-borne bacterial pathogens by use of a novel 16S rRNA gene PCR-ligase detection reaction-capillary electrophoresis assay. J Clin Microbiol. 2007 Jun; 45(6):1927-35.
Pingle MR, Granger K, Feinberg P, Shatsky R, Sterling B, Rundell M, Spitzer E, Larone D, Golightly L, Barany F. PMID: 17428930.
View in:
PubMed Mentions:
17 Fields:
Translation:
HumansCells